Louis Edward Tamayo

This profile gathers the share dealings of Louis Edward Tamayo in Lexeo Therapeutics, Inc. Between 29 August 2025 and 18 August 2026, the trades on record add up to 3 filings.

Every open-market trade on record is a sale: 1 sale worth €17k. Outside the open market, there are 2 share grants. Since January 2026: no purchases and 1 sale on the market.

The record was last updated on 19 August 2026 with an open-market sale (€17k) in Lexeo Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.